M Samama

13.4k total citations · 3 hit papers
200 papers, 9.6k citations indexed

About

M Samama is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M Samama has authored 200 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Internal Medicine, 83 papers in Hematology and 82 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M Samama's work include Venous Thromboembolism Diagnosis and Management (89 papers), Blood Coagulation and Thrombosis Mechanisms (62 papers) and Atrial Fibrillation Management and Outcomes (54 papers). M Samama is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (89 papers), Blood Coagulation and Thrombosis Mechanisms (62 papers) and Atrial Fibrillation Management and Outcomes (54 papers). M Samama collaborates with scholars based in France, United States and Canada. M Samama's co-authors include Jeffrey I. Weitz, Grigoris Gerotziafas, L. Bara, Céline Guinet, David García, Trevor Baglin, Alain Leizorovicz, Carl‐Gustav Olsson, Louis Desjardins and C Janbon and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

M Samama

197 papers receiving 9.1k citations

Hit Papers

A Comparison of Enoxapari... 1999 2026 2008 2017 1999 2012 2008 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
    1999 1.1k citations M Samama, Alexander T. Cohen et al. profile →
  2. Parenteral Anticoagulants
    2012 721 citations David García, Trevor Baglin et al. CHEST Journal profile →
  3. Parenteral Anticoagulants
    2008 518 citations M Samama, Jeffrey I. Weitz et al. CHEST Journal profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M Samama 6.2k 5.6k 2.8k 2.4k 995 200 9.6k
Kenneth A. Bauer 7.6k 1.2× 6.4k 1.1× 5.4k 1.9× 3.0k 1.3× 1.4k 1.4× 201 13.6k
Vittorio Pengo 5.8k 0.9× 6.6k 1.2× 5.6k 2.0× 2.4k 1.0× 1.7k 1.7× 367 16.3k
Graham F. Pineo 8.9k 1.4× 7.2k 1.3× 1.6k 0.6× 4.2k 1.8× 1.2k 1.2× 116 12.1k
Franco Piovella 4.7k 0.8× 3.3k 0.6× 1.3k 0.5× 1.9k 0.8× 584 0.6× 90 6.3k
Pieter W. Kamphuisen 6.5k 1.0× 5.4k 1.0× 2.6k 0.9× 1.9k 0.8× 899 0.9× 230 10.9k
Paul A. Kyrle 5.8k 0.9× 3.9k 0.7× 6.2k 2.2× 2.6k 1.1× 1.0k 1.0× 209 11.8k
Anthonie W.A. Lensing 9.2k 1.5× 6.8k 1.2× 2.7k 1.0× 3.1k 1.3× 1.2k 1.2× 91 11.0k
Sebastian Schellong 6.6k 1.1× 5.5k 1.0× 1.2k 0.4× 2.2k 0.9× 657 0.7× 226 8.0k
Armando D’Angelo 2.6k 0.4× 2.4k 0.4× 3.0k 1.1× 1.9k 0.8× 865 0.9× 192 9.1k
Giancarlo Agnelli 11.7k 1.9× 8.7k 1.5× 2.5k 0.9× 3.9k 1.7× 1.1k 1.1× 180 13.9k

Countries citing papers authored by M Samama

Since Specialization
Citations

This map shows the geographic impact of M Samama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Samama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Samama more than expected).

Fields of papers citing papers by M Samama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Samama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Samama. The network helps show where M Samama may publish in the future.

Co-authorship network of co-authors of M Samama

This figure shows the co-authorship network connecting the top 25 collaborators of M Samama. A scholar is included among the top collaborators of M Samama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Samama. M Samama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samama, M, et al.. (2014). Caractéristiques pharmacologiques et cliniques des inhibiteurs directs du facteur Xa : rivaroxaban, apixaban, edoxaban et betrixaban. Journal des Maladies Vasculaires. 39(3). 183–194. 3 indexed citations
2.
3.
García, David, Trevor Baglin, Jeffrey I. Weitz, & M Samama. (2012). Parenteral Anticoagulants. CHEST Journal. 141(2). e24S–e43S. 721 indexed citations breakdown →
4.
Samama, M & Céline Guinet. (2011). Laboratory assessment of new anticoagulants. Clinical Chemistry and Laboratory Medicine (CCLM). 49(5). 761–772. 130 indexed citations
5.
Harenberg, Job, A. K. Kakkar, D. BERGQVIST, et al.. (2009). Recommendations on biosimilar low‐molecular‐weight heparins. Journal of Thrombosis and Haemostasis. 7(7). 1222–1225. 26 indexed citations
6.
Samama, M & Grigoris Gerotziafas. (2009). Newer anticoagulants in 2009. Journal of Thrombosis and Thrombolysis. 29(1). 92–104. 36 indexed citations
7.
Samama, M, et al.. (2009). Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?. Blood Coagulation & Fibrinolysis. 20(3). 207–214. 6 indexed citations
8.
Elalamy, Ismaı̈l, Grigoris Gerotziafas, Anna D. Petropoulou, et al.. (2007). Circulating platelet–leukocyte aggregates: A marker of microvascular injury in diabetic patients. Thrombosis Research. 121(6). 843–848. 57 indexed citations
9.
Gerotziafas, Grigoris, Anna D. Petropoulou, E Verdy, M Samama, & Ismaı̈l Elalamy. (2007). Effect of the anti‐factor Xa and anti‐factor IIa activities of low‐molecular‐weight heparins upon the phases of thrombin generation. Journal of Thrombosis and Haemostasis. 5(5). 955–962. 90 indexed citations
10.
Desjardins, Louis, L. Bara, Florent Boutitie, et al.. (2004). Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study. Archives of Pathology & Laboratory Medicine. 128(5). 519–526. 38 indexed citations
11.
Elalamy, Ismaı̈l, et al.. (2003). In vitro effect of melagatran and lepirudin on clot-bound thrombin. Thrombosis Research. 110(4). 249–252. 4 indexed citations
12.
Walenga, Jeanine M., et al.. (2002). Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent. Expert Opinion on Investigational Drugs. 11(3). 397–407. 95 indexed citations
13.
Samama, M & Grigoris Gerotziafas. (2000). Comparative Pharmacokinetics of LMWHs. Seminars in Thrombosis and Hemostasis. Volume 26(Number s1). 31–38. 113 indexed citations
14.
Samama, M, L. Bara, & Isabelle Gouin‐Thibault. (1996). New Data on the Pharmacology of Heparin and Low Molecular Weight Heparins. Drugs. 52(Supplement 7). 8–15. 28 indexed citations
15.
16.
17.
18.
Tirmarche, M., et al.. (1984). Discriminant Study of Platelet Volume Indices in the Etiological Diagnosis of Thrombocytopenia. Acta Haematologica. 71(1). 25–31. 3 indexed citations
19.
Soria, J., Claudine Soria, Olivier F. Bertrand, & M Samama. (1978). Fibrinogen and platelet aggregation. Role of the glycopeptidic part and of the fibrinopeptide B. Biochemical and Biophysical Research Communications. 82(2). 442–450. 6 indexed citations
20.
Marchal, G, G Duhamel, M Samama, & Georges Flandrin. (1964). [MASSIVE THROMBOSIS OF THE VESSELS OF AN EXTREMITY DURING A CONGENITAL HYPOFIBRINEMIA].. PubMed. 4. 81–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth A. Bauer Breakdown of academic impact, for papers by Vittorio Pengo Breakdown of academic impact, for papers by Graham F. Pineo Breakdown of academic impact, for papers by Franco Piovella Breakdown of academic impact, for papers by Pieter W. Kamphuisen Breakdown of academic impact, for papers by Paul A. Kyrle Breakdown of academic impact, for papers by Anthonie W.A. Lensing Breakdown of academic impact, for papers by Sebastian Schellong Breakdown of academic impact, for papers by Armando D’Angelo Breakdown of academic impact, for papers by Giancarlo Agnelli
Rankless by CCL
2026